Chronic hepatitis C treatment in a cystic fibrosis patient in the pulmonary pre-transplant stage.
Adán-Merino
L
L
Department of Gastroenterology, La Paz University Hospital. Madrid, Spain. luisaadan@gmail.com
Olveira-Martín
A
A
Prados
C
C
Gea-Rodríguez
F
F
Castillo-Grau
P
P
Martín-Arranz
E
E
Sáenz
J C
JC
Segura-Cabral
J M
JM
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications* / Q000601:surgery*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D016040:Lung Transplantation / Q000502:physiology*; D008297:Male; D011168:Portal System / Q000473:pathology; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons